Increasing evidence showed that circulating galectin-3, an emerging biomarker of myocardial fibrosis, immune activation, and enhanced inflammation, has been involved in the pathogenesis of many cardiovascular diseases [9,10]. The gene discussed is LGALS3; the disease is cardiovascular disorder.